Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC [Phase 1, Phase 2]
Phase 1/2 trial of ATL001 in advanced unresectable or metastatic non-small cell lung cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of TBio-4101 (TIL) with pembrolizumab in advanced solid tumors has been terminated; the trial includes multiple indications su…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) [Phase 2]
Phase 2 clinical trial update on pixatimod (PG545) plus nivolumab in PD-1 relapsed/refractory metastatic melanoma and non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Phase 3 trial update for savolitinib in locally advanced or metastatic non-small cell lung cancer; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. [Phase 1, Phase 2]
Phase I/II study of oral vorinostat combined with erlotinib in non-small cell lung cancer patients with EGFR mutations who progressed on erl…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: MGD019 DART® Protein in Unresectable/Metastatic Cancer [Phase 1]
MGD019, a DART protein from MacroGenics, is being studied in a Phase 1 trial for unresectable/metastatic cancers, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR [Phase 3]
A Phase III trial comparing Tarceva (erlotinib) to standard chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating nivolumab with or without ipilimumab or chemotherapy in patients with previously untreated stage I-IIIA non-small c…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
The study update reports observations of taste and smell dysfunction occurring more than two years after initiation of immune checkpoint inh…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pre-incisional ketorolac in surgery for non-small cell lung cancer or renal cell carcinoma has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients [Phase 1]
Phase 1 trial evaluating safety and tolerability of combining sintilimab with radiotherapy in stage IV non-small cell lung cancer. Results e…
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC [Phase 2]
Phase 2 trial evaluating NAP in combination with docetaxel after obinutuzumab pretreatment in advanced or metastatic non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
The study reports results for using afatinib as first-line therapy in patients with EGFR mutation-positive, advanced non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC [Phase 2]
A Phase 2 trial evaluated combining osimertinib with aspirin to overcome resistance to first-generation EGFR-TKIs in non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is planned to compare HLX17 with pembrolizumab (Keytruda) as first-line treatment in advanced non-squamous non-smal…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating bemcentinib in combination with erlotinib in non-small cell lung cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy combined with immune checkpoint inhibitors in ALK-rearranged non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006) [Phase 3]
Phase 3 trial evaluating pemetrexed with platinum-based chemotherapy and pembrolizumab, with or without lenvatinib, as first-line therapy fo…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Quaratusugene ozeplasmid (Reqorsa) in combination with pembrolizumab for previously treated non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer [Phase 3]
Phase 3 study comparing brigatinib with alectinib in adults with ALK-positive non-small cell lung cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Effect of Omega 3 Enriched Oral Nutritional Supplement on Nutritional Status of CRC and NSCLC Patients [NA]
This completed clinical trial evaluated the impact of an Omega-3 enriched oral nutritional supplement on the nutritional status of colorecta…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Stage III NSCLC RWE in Chinese Patients
This clinical trial update reports completion of real-world evidence evaluating Stage III non-small cell lung cancer in Chinese patients, sp…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with plinabulin and docetaxel for metastatic non-small cell lung cancer after…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers [Phase 1, Phase 2]
Phase 1/2 trial update evaluating nivolumab plus ABI-009 (nab-rapamycin) in patients with advanced sarcoma and selected cancers, with result…